Top

European Radiology

Published in:

01-09-2018 | Neuro

Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis

Authors: Chong Hyun Suh, Ho Sung Kim, Seung Chai Jung, Choong Gon Choi, Sang Joon Kim

Published in: European Radiology | Issue 9/2018

Abstract

Objectives

Differentiation of glioma from brain metastasis is clinically crucial because it affects the clinical outcome of patients and alters patient management. Here, we present a systematic review and meta-analysis of the currently available data on perfusion magnetic resonance imaging (MRI) for differentiating glioma from brain metastasis, assessing MRI protocols and parameters.

Methods

A computerised search of Ovid-MEDLINE and EMBASE databases was performed up to 3 October 2017, to find studies on the diagnostic performance of perfusion MRI for differentiating glioma from brain metastasis. Pooled summary estimates of sensitivity and specificity were obtained using hierarchical logistic regression modelling. We conducted meta-regression and subgroup analyses to explain the effects of the study heterogeneity.

Results

Eighteen studies with 900 patients were included. The pooled sensitivity and specificity were 90% (95% CI, 84–94%) and 91% (95% CI, 84–95%), respectively. The area under the hierarchical summary receiver operating characteristic curve was 0.96 (95% CI, 0.94–0.98). The meta-regression showed that the percentage of glioma in the study population and the study design were significant factors affecting study heterogeneity. In a subgroup analysis including patients with glioblastoma only, the pooled sensitivity was 92% (95% CI, 84–97%) and the pooled specificity was 94% (95% CI, 85–98%).

Conclusions

Although various perfusion MRI techniques were used, the current evidence supports the use of perfusion MRI to differentiate glioma from brain metastasis. In particular, perfusion MRI showed excellent diagnostic performance for differentiating glioblastoma from brain metastasis.

Key Points

• Perfusion MRI shows high diagnostic performance for differentiating glioma from brain metastasis.

• The pooled sensitivity was 90% and pooled specificity was 91%.

• Peritumoral rCBV derived from DSC is a relatively well-validated.

Giese A, Westphal M (2001) Treatment of malignant glioma: a problem beyond the margins of resection. J Cancer Res Clin Oncol 127:217–225CrossRefPubMed

Wesseling P, Ruiter DJ, Burger PC (1997) Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neurooncol 32:253–265CrossRefPubMed

Long DM (1979) Capillary ultrastructure in human metastatic brain tumors. J Neurosurg 51:53–58CrossRefPubMed

Watanabe M, Tanaka R, Takeda N (1992) Magnetic resonance imaging and histopathology of cerebral gliomas. Neuroradiology 34:463–469CrossRefPubMed

Strugar J, Rothbart D, Harrington W, Criscuolo GR (1994) Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 81:560–566CrossRefPubMed

Bauer AH, Erly W, Moser FG, Maya M, Nael K (2015) Differentiation of solitary brain metastasis from glioblastoma multiforme: a predictive multiparametric approach using combined MR diffusion and perfusion. Neuroradiology 57:697–703CrossRefPubMed

Blasel S, Jurcoane A, Franz K, Morawe G, Pellikan S, Hattingen E (2010) Elevated peritumoural rCBV values as a mean to differentiate metastases from high-grade gliomas. Acta Neurochir 152:1893–1899CrossRefPubMed

Bulakbasi N, Kocaoglu M, Farzaliyev A, Tayfun C, Ucoz T, Somuncu I (2005) Assessment of diagnostic accuracy of perfusion MR imaging in primary and metastatic solitary malignant brain tumors. AJNR Am J Neuroradiol 26:2187–2199PubMed

Cha S, Lupo JM, Chen MH et al (2007) Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 28:1078–1084CrossRefPubMed

10.

Chen R, Wang S, Poptani H, Melhem ER, Herskovits EH (2013) A Bayesian diagnostic system to differentiate glioblastomas from solitary brain metastases. Neuroradiol J 26:175–183CrossRefPubMedPubMedCentral

11.

Ganbold M, Harada M, Khashbat D, Abe T, Kageji T, Nagahiro S (2017) Differences in high-intensity signal volume between arterial spin labeling and contrast-enhanced T1-weighted imaging may be useful for differentiating glioblastoma from brain metastasis. J Med Invest 64:58–63CrossRefPubMed

12.

Hakyemez B, Erdogan C, Gokalp G, Dusak A, Parlak M (2010) Solitary metastases and high-grade gliomas: radiological differentiation by morphometric analysis and perfusion-weighted MRI. Clin Radiol 65:15–20CrossRefPubMed

13.

Lin L, Xue Y, Duan Q et al (2016) The role of cerebral blood flow gradient in peritumoral edema for differentiation of glioblastomas from solitary metastatic lesions. Oncotarget 7:69051–69059PubMedPubMedCentral

14.

Ma JH, Kim HS, Rim NJ, Kim SH, Cho KG (2010) Differentiation among glioblastoma multiforme, solitary metastatic tumor, and lymphoma using whole-tumor histogram analysis of the normalized cerebral blood volume in enhancing and perienhancing lesions. AJNR Am J Neuroradiol 31:1699–1706CrossRefPubMed

15.

Mouthuy N, Cosnard G, Abarca-Quinones J, Michoux N (2012) Multiparametric magnetic resonance imaging to differentiate high-grade gliomas and brain metastases. J Neuroradiol 39:301–307CrossRefPubMed

16.

Server A, Orheim TE, Graff BA, Josefsen R, Kumar T, Nakstad PH (2011) Diagnostic examination performance by using microvascular leakage, cerebral blood volume, and blood flow derived from 3-T dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in the differentiation of glioblastoma multiforme and brain metastasis. Neuroradiology 53:319–330CrossRefPubMed

17.

Sparacia G, Gadde JA, Iaia A, Sparacia B, Midiri M (2016) Usefulness of quantitative peritumoural perfusion and proton spectroscopic magnetic resonance imaging evaluation in differentiating brain gliomas from solitary brain metastases. Neuroradiol J 29:160–167CrossRefPubMedPubMedCentral

18.

Sunwoo L, Yun TJ, You SH et al (2016) Differentiation of glioblastoma from brain metastasis: qualitative and quantitative analysis using arterial spin labeling MR imaging. PLoS One 11:e0166662CrossRefPubMedPubMedCentral

19.

Tsougos I, Svolos P, Kousi E et al (2012) Differentiation of glioblastoma multiforme from metastatic brain tumor using proton magnetic resonance spectroscopy, diffusion and perfusion metrics at 3 T. Cancer Imaging 12:423–436CrossRefPubMedPubMedCentral

20.

Weber MA, Zoubaa S, Schlieter M et al (2006) Diagnostic performance of spectroscopic and perfusion MRI for distinction of brain tumors. Neurology 66:1899–1906CrossRefPubMed

21.

Young GS, Setayesh K (2009) Spin-echo echo-planar perfusion MR imaging in the differential diagnosis of solitary enhancing brain lesions: distinguishing solitary metastases from primary glioma. AJNR Am J Neuroradiol 30:575–577CrossRefPubMed

22.

Zhang H, Rodiger LA, Zhang G, Oudkerk M (2009) Differentiation between supratentorial single brain metastases and high grade astrocytic tumors: an evaluation of different DSC MRI Measurements. Neuroradiol J 22:369–377CrossRefPubMed

23.

Zhao J, Yang ZY, Luo BN, Yang JY, Chu JP (2015) Quantitative evaluation of diffusion and dynamic contrast-enhanced MR in tumor parenchyma and peritumoral area for distinction of brain tumors. PLoS One 10:e0138573CrossRefPubMedPubMedCentral

24.

Liberati A, Altman DG, Tetzlaff J et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:W65–W94CrossRefPubMed

25.

Whiting PF, Rutjes AW, Westwood ME et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155:529–536CrossRefPubMed

26.

Higgins J, Green S Cochrane handbook for systematic reviews of interventions, version 5.1.0. The Cochrane Collaboration. http:// handbook.cochrane.org/chapter_9/9_5_2_ identifying_and_measuring_heterogeneity. htm. Updated March 2011. Accessed 2 October 2017

27.

Deville WL, Buntinx F, Bouter LM et al (2002) Conducting systematic reviews of diagnostic studies: didactic guidelines. BMC Med Res Methodol 2:9CrossRefPubMedPubMedCentral

28.

Suh CH, Park SH (2016) Successful publication of systematic review and meta-analysis of studies evaluating diagnostic test accuracy. Korean J Radiol 17:5–6CrossRefPubMedPubMedCentral

29.

Kim KW, Lee J, Choi SH, Huh J, Park SH (2015) Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers—Part I. General guidance and tips. Korean J Radiol 16:1175–1187CrossRefPubMedPubMedCentral

30.

Lee J, Kim KW, Choi SH, Huh J, Park SH (2015) Systematic review and meta-analysis of studies evaluating diagnostic test accuracy: a practical review for clinical researchers—Part II. Statistical methods of meta-analysis. Korean J Radiol 16:1188–1196CrossRefPubMedPubMedCentral

31.

Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 58:882–893CrossRefPubMed

32.

Abe T, Mizobuchi Y, Sako W et al (2015) Clinical significance of discrepancy between arterial spin labeling images and contrast-enhanced images in the diagnosis of brain tumors. Magn Reson Med Sci 14:313–319CrossRefPubMed

33.

Aprile I, Armadori M, Conti G, Ottaviano I, Ranaldi A, Ottaviano P (2008) MR perfusion imaging of intracranial tumors: a retrospective study of 218 patients. Neuroradiology Journal 21:472–489CrossRefPubMed

34.

Aprile I, Roscetti M, Giulianelli G, Muti M, Ottaviano P (2007) Cerebral MR perfusion imaging analysis of peritumoral tissue. Neuroradiol J 20:656–661CrossRefPubMed

35.

Bazyar S, Ramalho J, Eldeniz C, An H, Lee YZ (2016) Comparison of cerebral blood volume and plasma volume in untreated intracranial tumors. PLoS One 11:e0161807CrossRefPubMedPubMedCentral

36.

Bendini M, Marton E, Feletti A et al (2011) Primary and metastatic intraaxial brain tumors: prospective comparison of multivoxel 2D chemical-shift imaging (CSI) proton MR spectroscopy, perfusion MRI, and histopathological findings in a group of 159 patients. Acta Neurochir 153:403–412CrossRefPubMed

37.

Calli C, Kitis O, Yunten N, Yurtseven T, Islekel S, Akalin T (2006) Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 58:394–403CrossRefPubMed

38.

Chiang IC, Kuo YT, Lu CY et al (2004) Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings. Neuroradiology 46:619–627CrossRefPubMed

39.

Cho SK, Na DG, Ryoo JW et al (2002) Perfusion MR imaging: clinical utility for the differential diagnosis of various brain tumors. Korean J Radiol 3:171–179CrossRefPubMedPubMedCentral

40.

Chu JP, Mak HK, Yau KK et al (2012) Pilot study on evaluation of any correlation between MR perfusion (Ktrans) and diffusion (apparent diffusion coefficient) parameters in brain tumors at 3 Tesla. Cancer Imaging 12:1–6CrossRefPubMedPubMedCentral

41.

Gaudino S, Di Lella GM, Russo R et al (2012) Magnetic resonance imaging of solitary brain metastases: main findings of nonmorphological sequences. Radiol Med 117:1225–1241CrossRefPubMed

42.

Jiang J, Zhao L, Zhang Y et al (2014) Comparative analysis of arterial spin labeling and dynamic susceptibility contrast perfusion imaging for quantitative perfusion measurements of brain tumors. Int J Clin Exp Pathol 7:2790–2799PubMedPubMedCentral

43.

Jung BC, Arevalo-Perez J, Lyo JK et al (2016) Comparison of glioblastomas and brain metastases using dynamic contrast-enhanced perfusion MRI. J Neuroimaging 26:240–246CrossRefPubMed

44.

Kremer S, Grand S, Berger F et al (2003) Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases. Neuroradiology 45:44–49CrossRefPubMed

45.

Law M, Cha S, Knopp EA, Johnson G, Arnett J, Litt AW (2002) High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222:715–721CrossRefPubMed

46.

Lehmann P, Monet P, de Marco G et al (2010) A comparative study of perfusion measurement in brain tumours at 3 Tesla MR: Arterial spin labeling versus dynamic susceptibility contrast-enhanced MRI. Eur Neurol 64:21–26CrossRefPubMed

47.

Lehmann P, Saliou G, de Marco G et al (2012) Cerebral peritumoral oedema study: does a single dynamic MR sequence assessing perfusion and permeability can help to differentiate glioblastoma from metastasis? Eur J Radiol 81:522–527CrossRefPubMed

48.

Ludemann L, Grieger W, Wurm R, Wust P, Zimmer C (2005) Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI. Magn Reson Imaging 23:833–841CrossRefPubMed

49.

Rizzo L, Crasto SG, Moruno PG et al (2009) Role of diffusion- and perfusion-weighted MR imaging for brain tumour characterisation. Radiol Med 114:645–659CrossRefPubMed

50.

Rollin N, Guyotat J, Streichenberger N, Honnorat J, Tran Minh VA, Cotton F (2006) Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology 48:150–159CrossRefPubMed

51.

Senturk S, Oguz KK, Cila A (2009) Dynamic contrast-enhanced susceptibility-weighted perfusion imaging of intracranial tumors: a study using a 3T MR scanner. Diagn Interv Radiol 15:3–12PubMed

52.

Essig M, Waschkies M, Wenz F, Debus J, Hentrich HR, Knopp MV (2003) Assessment of brain metastases with dynamic susceptibility-weighted contrast-enhanced MR imaging: initial results. Radiology 228:193–199CrossRefPubMed

53.

Hoefnagels FW, Lagerwaard FJ, Sanchez E et al (2009) Radiological progression of cerebral metastases after radiosurgery: assessment of perfusion MRI for differentiating between necrosis and recurrence. J Neurol 256:878–887CrossRefPubMedPubMedCentral

54.

Huang J, Wang AM, Shetty A et al (2011) Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling. Magn Reson Imaging 29:993–1001CrossRefPubMed

55.

Jakubovic R, Sahgal A, Ruschin M, Pejovic-Milic A, Milwid R, Aviv RI (2014) Non tumor perfusion changes following stereotactic radiosurgery to brain metastases. Technol Cancer Res Treat

56.

Jakubovic R, Sahgal A, Soliman H et al (2014) Magnetic resonance imaging-based tumour perfusion parameters are biomarkers predicting response after radiation to brain metastases. Clin Oncol (R Coll Radiol) 26:704–712CrossRef

57.

Kang TW, Kim ST, Byun HS et al (2009) Morphological and functional MRI, MRS, perfusion and diffusion changes after radiosurgery of brain metastasis. Eur J Radiol 72:370–380CrossRefPubMed

58.

Kapadia A, Mehrabian H, Conklin J et al (2017) Temporal evolution of perfusion parameters in brain metastases treated with stereotactic radiosurgery: comparison of intravoxel incoherent motion and dynamic contrast enhanced MRI. J Neurooncol

59.

Kim DY, Kim HS, Goh MJ, Choi CG, Kim SJ (2014) Utility of intravoxel incoherent motion MR imaging for distinguishing recurrent metastatic tumor from treatment effect following gamma knife radiosurgery: initial experience. AJNR Am J Neuroradiol 35:2082–2090CrossRefPubMed

60.

Koh MJ, Kim HS, Choi CG, Kim SJ (2015) Which is the best advanced MR imaging protocol for predicting recurrent metastatic brain tumor following gamma-knife radiosurgery: focused on perfusion method. Neuroradiology 57:367–376CrossRefPubMed

61.

Lai G, Mahadevan A, Hackney D et al (2015) Diagnostic Accuracy of PET, SPECT, and arterial spin-labeling in differentiating tumor recurrence from necrosis in cerebral metastasis after stereotactic radiosurgery. AJNR Am J Neuroradiol 36:2250–2255CrossRefPubMed

62.

Mitsuya K, Nakasu Y, Horiguchi S et al (2010) Perfusion weighted magnetic resonance imaging to distinguish the recurrence of metastatic brain tumors from radiation necrosis after stereotactic radiosurgery. J Neurooncol 99:81–88CrossRefPubMed

63.

Weber MA, Thilmann C, Lichy MP et al (2004) Assessment of irradiated brain metastases by means of arterial spin-labeling and dynamic susceptibility-weighted contrast-enhanced perfusion MRI: initial results. Invest Radiol 39:277–287CrossRefPubMed

64.

Fayed N, Davila J, Medrano J, Olmos S (2008) Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Eur J Radiol 67:427–433CrossRefPubMed

65.

Huang BY, Kwock L, Castillo M, Smith JK (2010) Association of choline levels and tumor perfusion in brain metastases assessed with proton MR spectroscopy and dynamic susceptibility contrast-enhanced perfusion weighted MRI. Technol Cancer Res Treat 9:327–337CrossRefPubMed

66.

Svolos P, Tsolaki E, Kapsalaki E et al (2013) Investigating brain tumor differentiation with diffusion and perfusion metrics at 3T MRI using pattern recognition techniques. Magn Reson Imaging 31:1567–1577CrossRefPubMed

67.

Tsolaki E, Svolos P, Kousi E et al (2013) Automated differentiation of glioblastomas from intracranial metastases using 3T MR spectroscopic and perfusion data. Int J Comput Assist Radiol Surg 8:751–761CrossRefPubMed

68.

Tsuchiya K, Aoki S, Shimoji K, Mori H, Kunimatsu A (2013) Consecutive acquisition of time-resolved contrast-enhanced MR angiography and perfusion MR imaging with added dose of gadolinium-based contrast agent aids diagnosis of suspected brain metastasis. Magn Reson Med Sci 12:87–93CrossRefPubMed

69.

Zach L, Guez D, Last D et al (2012) Delayed contrast extravasation MRI for depicting tumor and non-tumoral tissues in primary and metastatic brain tumors. PLoS One 7:e52008CrossRefPubMedPubMedCentral

70.

Abe T, Mizobuchi Y, Nakajima K et al (2015) Diagnosis of brain tumors using dynamic contrast-enhanced perfusion imaging with a short acquisition time. Springerplus 4:88CrossRefPubMedPubMedCentral

71.

Al-Okaili RN, Krejza J, Woo JH et al (2007) Intraaxial brain masses: MR imaging-based diagnostic strategy—initial experience. Radiology 243:539–550CrossRefPubMed

72.

Lu S, Gao Q, Yu J et al (2016) Utility of dynamic contrast-enhanced magnetic resonance imaging for differentiating glioblastoma, primary central nervous system lymphoma and brain metastatic tumor. Eur J Radiol 85:1722–1727CrossRefPubMed

73.

Mangla R, Kolar B, Zhu T, Zhong J, Almast J, Ekholm S (2011) Percentage signal recovery derived from MR dynamic susceptibility contrast imaging is useful to differentiate common enhancing malignant lesions of the brain. AJNR Am J Neuroradiol 32:1004–1010CrossRefPubMed

74.

Wang S, Kim S, Chawla S et al (2011) Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 32:507–514CrossRefPubMed

75.

Park SM, Kim HS, Jahng GH, Ryu CW, Kim SY (2010) Combination of high-resolution susceptibility-weighted imaging and the apparent diffusion coefficient: added value to brain tumour imaging and clinical feasibility of non-contrast MRI at 3 T. Br J Radiol 83:466–475CrossRefPubMedPubMedCentral

76.

Perfusion, Diffusion and Flow-MRI Biomarker Committee of the Quantitative Imaging Biomarkers Alliance (QIBA). Available at: http://qibawiki.rsna.org/index.php/Perfusion,_Diffusion_and_Flow-MRI_Biomarker_Ctte.

77.

Welker K, Boxerman J, Kalnin A, Kaufmann T, Shiroishi M, Wintermark M (2015) ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain. AJNR Am J Neuroradiol 36:E41–E51CrossRefPubMedPubMedCentral

78.

Hatzoglou V, Tisnado J, Mehta A et al (2017) Dynamic contrast-enhanced MRI perfusion for differentiating between melanoma and lung cancer brain metastases. Cancer Med 6:761–767CrossRefPubMedPubMedCentral

79.

Kim HS, Goh MJ, Kim N, Choi CG, Kim SJ, Kim JH (2014) Which combination of MR imaging modalities is best for predicting recurrent glioblastoma? Study of diagnostic accuracy and reproducibility. Radiology 273:831–843CrossRefPubMed

80.

Leeflang MM, Bossuyt PM, Irwig L (2009) Diagnostic test accuracy may vary with prevalence: implications for evidence-based diagnosis. J Clin Epidemiol 62:5–12CrossRefPubMed

Title: Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis
Authors: Chong Hyun Suh
Ho Sung Kim
Seung Chai Jung
Choong Gon Choi
Sang Joon Kim
Publication date: 01-09-2018
Publisher: Springer Berlin Heidelberg
Published in: European Radiology / Issue 9/2018
Print ISSN: 0938-7994
Electronic ISSN: 1432-1084
DOI: https://doi.org/10.1007/s00330-018-5335-0

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Perfusion MRI as a diagnostic biomarker for differentiating glioma from brain metastasis: a systematic review and meta-analysis

Abstract

Objectives

Methods

Results

Conclusions

Key Points

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Objectives

Methods

Results

Conclusions

Key Points

Please log in to get access to this content

Other articles of this Issue 9/2018

Conventional radiography in juvenile idiopathic arthritis: Joint recommendations from the French societies for rheumatology, radiology and paediatric rheumatology

CT analysis of the aorta in giant-cell arteritis: a case-control study

Percutaneous transhepatic intrahepatic portosystemic shunt for variceal bleeding with chronic portal vein occlusion after splenectomy

Monitoring neurointerventional radiation doses using dose-tracking software: implications for the establishment of local diagnostic reference levels

Facial nerve tractography: A new tool for the detection of perineural spread in parotid cancers

Combined percutaneous radiofrequency ablation and ethanol injection versus hepatic resection for 2.1–5.0 cm solitary hepatocellular carcinoma: a retrospective comparative multicentre study